title: Neural therapy in the treatment of multiple sclerosis.
abstract: OBJECTIVE
  To assess the therapeutic potential of neural therapy, a modified form of acupuncture, in multiple sclerosis.
  
  
  METHODS
  A pilot study followed by a double-blind, placebo-controlled randomized study.
  
  
  METHODS
  The Glasgow Homoeopathic Hospital, Glasgow, Scotland.
  
  
  METHODS
  An unselected group of 61 new patients referred to the Glasgow Homoeopathic Hospital, suffering from any type of multiple sclerosis, who fulfilled the criteria of Schumacher and had a Disability Status Score (DSS) or Expanded Disability Status Score (EDSS) grade of 1-7.
  
  
  METHODS
  Neural therapy, which is the injection of small amounts of local anesthetic without adrenaline, into specific trigger points in the ankles and around the greatest circumference of the skull.
  
  
  METHODS
  Improvements in the Kurtzke scales and the DSS or EDSS assessments.
  
  
  RESULTS
  Sixty-five percent (65%) of the patients in the pilot study (n = 40) and seventy-six percent (76%) of the patients in the double-blind trial (n = 21) benefitted from this treatment as assessed by Kurtzke scale improvements. On long-term follow-up of 2.0 to 3.5 years, more than 50% of the patients continued to show improved Kurtzke scale ratings. Improvements could be rapid. No toxic side effects were noted when injections were administered at a frequency of once or twice weekly or less.
  
  
  CONCLUSIONS
  Neural therapy is an effective, nontoxic and inexpensive treatment for multiple sclerosis that can confer both immediate and long-term benefits.
authors.affiliation: Glasgow Homoeopathic Hospital, Scotland.
authors.forename: R G
authors.initials: RG
authors.lastname: Gibson
authors.forename: S L
authors.initials: SL
authors.lastname: Gibson
mesh_terms: D000328:Adult; D000772:Anesthesia, Local; D000779:Anesthetics, Local / Q000008:administration & dosage*; D000843:Ankle Joint; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy*; D009407:Nerve Block / Q000379:methods; D010865:Pilot Projects; D012720:Severity of Illness Index; D012886:Skull; D016896:Treatment Outcome
chemical_list: D000779:Anesthetics, Local